{"id":"W2748154165","doi":"10.1016/s1470-2045(17)30471-0","title":"Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Clinical endpoint; Everolimus; Placebo; Discontinuation; Quality of life (healthcare); Internal medicine; Adverse effect; Clinical trial; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001116549,0.0004695961,0.002805524,0.0002560326,0.0004007898,0.00004387717,0.0006112492,0.00002759032,0.0001390148],"category_scores_gemma":[0.005677097,0.0002916667,0.0002623343,0.0002052057,0.0004793176,0.0002414529,0.0001500237,0.0008734588,0.00001272003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000353603,"about_ca_system_score_gemma":0.001227501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003858456,"about_ca_topic_score_gemma":0.001666022,"domain_scores_codex":[0.994923,0.0008937078,0.001533942,0.0006881415,0.0006759763,0.001285241],"domain_scores_gemma":[0.9925116,0.003757385,0.001891215,0.001019973,0.0003384663,0.0004813316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.978978,0.002934964,0.01461494,0.0002897837,0.0003072801,0.0003695979,0.00005318797,0.0003951794,0.0000902537,0.00002401494,0.00121923,0.0007236191],"study_design_scores_gemma":[0.9594001,0.0199739,0.01722681,0.0001966249,0.0002160263,0.0001600064,0.000115046,0.002140365,0.00007900728,0.00001241136,0.0002595789,0.0002201448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9732761,0.0001069983,0.0001015496,0.007462499,0.0008237675,0.01773398,0.00008744597,0.00006794884,0.0003396909],"genre_scores_gemma":[0.9962328,0.00009619702,0.0006426052,0.0002807805,0.0003963478,0.001761751,0.000162421,0.00006907577,0.0003580254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02295668,"threshold_uncertainty_score":0.9999536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09983468570026899,"score_gpt":0.4149173118146561,"score_spread":0.3150826261143871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}